SIGA targeted a 2027 FDA filing: what it means for SIGA stock

Published on 10/16/2026 at 04:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

SIGA delivered USD 38.0 million of product revenue in the second quarter. For SIGA stock, cash stood at USD 118.0 million on June 30, 2026.

Pipeline and financial context

SIGA targeted an FDA submission for pediatric post-exposure prophylaxis in the first half of 2027.
Six-month product-related revenue reached USD 41.0 million through June 30, 2026.
SIGA Technologies had a market capitalization of USD 229.2 million on October 15, 2026.

SIGA, US8269171067, Illustration mit AI erstellt.

SIGA Technologies (ISIN US8269171067) targeted an FDA submission for post-exposure prophylaxis in the first half of 2027, according to the company's August 6, 2026 earnings call transcript published by Yahoo Finance. The program gives the smallpox antiviral TPOXX a development angle beyond existing government procurement.

Pipeline carries a 2027 date

Management said the Centers for Disease Control and Prevention was advancing immunogenicity work for the post-exposure prophylaxis program. SIGA targeted the FDA submission for the first half of 2027, while pediatric phase one study results were expected by year-end, according to Yahoo Finance.

What do the latest results show?

SIGA generated USD 41.0 million of product-related revenue in the six months ended June 30, 2026, compared with USD 6.2 million in the first quarter alone. Second-quarter product-related revenue reached USD 38.0 million, including USD 24.0 million from intravenous TPOXX deliveries to the U.S. Strategic National Stockpile and USD 13.0 million from international customers, according to Yahoo Finance.

Three dated SIGA developments

On August 6, 2026, SIGA reported USD 41.0 million of product-related revenue for the first six months of 2026. On August 6, management also described the USD 13.0 million Asia-Pacific order delivered during the second quarter. On October 2, 2026, MarketBeat reported that Bank of America had acquired 427,275 SIGA shares during the second quarter.

Next reporting date is November 5

MarketBeat lists November 5, 2026, as SIGA's estimated next earnings date. The timing places the next results ahead of the company's 2027 regulatory milestone and should give investors another reading on deliveries and cash use.

Stock context for investors

SIGA's Nasdaq closing price was USD 3.19 on October 15, 2026 at 4:00 p.m. ET. The company held USD 117.6 million in cash and no debt as of June 30, 2026, while the 2027 filing target and the uneven delivery cycle remain central to the investment case.